Systematic reviews of oral complications from cancer therapies, Oral Care Study Group, MASCC/ISOO: Methodology and quality of the literature

Supportive Care in Cancer

Volumn 18, Issue 8, 2010, Pages 979-984

  Brennan, Michael T ^a   Elting, Linda S ^b   Spijkervet, Fred K L ^c  

^a CAROLINAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cancer therapies; Oral Care; Oral complications

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; DYSGEUSIA; HEALTH CARE COST; HUMAN; JAW OSTEONECROSIS; MEDICAL LITERATURE; METHODOLOGY; MOUTH DISEASE; MOUTH HYGIENE; MOUTH INFECTION; MOUTH PAIN; MYCOSIS; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; REVIEW; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; TREATMENT PLANNING; TRISMUS; XEROSTOMIA;

HUMANS; MOUTH DISEASES; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE;

EID: 77956463416     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-010-0856-3     Document Type: Review

References (12)

1. Dreizen S (1990) Description and incidence of oral complications. NCI Monogr 9:11-15
2. National Institutes of Health Consensus Development Conference on Oral Complications of Cancer Therapies: Diagnosis, Prevention, and Treatment. (1990) NCI Monogr 1-184
3. National Cancer Institute (2005) Cancer Literature in PubMed. Available from http://www.cancer.gov/search/cancer-literature/. Accessed 26 Sep
4. Smith BJ, Darzins PJ, Quinn M, Heller RF (1992) Modern methods of searching the medical literature. Med J Aust 157:603-611
5. Higgins JP, Green S (2005) Cochrane handbook for systematic reviews of interventions. [cited May 31]. Available from http://www.cochrane.dk/cochrane/ handbook/hbook.htm
6. (1989) Oral complications of cancer therapies: diagnosis, prevention, and treatment. Available from http://consensus.nih.gov/1989/ 1989OralComplicationsCancerTherapy073html.htm. [cited Apr. 17]; 7:1-11
7. Somerfield MR, Padberg JJ, Pfister DG, Bennett CL, Recht A, Smith TJ, Weeks JC, Winn RJ, Durant JR (2000) ASCO clinical practice guidelines: process, progress, pitfalls, and prospects. Class Pap Curr Comments 4:881-886
8. Baccaglini L, Brennan MT, Lockhart PB, Patton LL (2007) World Workshop on Oral Medicine IV: process and methodology for systematic review and developing management recommendations. Reference manual for management recommendations writing committees. OOOOE 103 Suppl: S3.e1-19
9. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST, Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100:2026-2046
10. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB, Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995-2025
11. Berard A, Bravo G (1998) Combining studies using effect sizes and quality scores: application to bone loss in postmenopausal women. J Clin Epidemiol 51:801-807
12. Efron B (1993) An introduction to the bootstrap. Chapman & Hall, New York